|Other Terms:||[ ]|
- Among bacterial species with higher abundance in the psoriasis gut microbiome, Bacteroides vulgatus and Parasutterella excrementihominis have been associated with other immune-mediated diseases.
- Increased intestinal colonization of Bacteroides vulgatus and elevated Bacteroides vulgatus reactive serum antibodies have been reported in ulcerative colitis patients.
- Moreover, colonization of Bacteroides vulgatus is sufficient to promote colitis in several animal models, which further supports the active role of Bacteroides vulgatus in development of colitis.
- The abundance of Akkermansia muciniphila was significantly reduced in patients with psoriasis .
- A. muciniphila is believed to have an important function in the pathogenesis of IBD and obesity; therefore, A. muciniphila, which is an indicator of health status, may be a key node for psoriasis as well as IBD and obesity. (1)
- The psoriatic subject showed a decrease in Firmicutes abundance and an increase in Proteobacteria abundance.
- An increase in Streptococcaceae, Rhodobacteraceae, Campylobacteraceae and Moraxellaceae has been observed in psoriatic subject.
- Antibiotic treatment resulted in a substantial increase in the order Lactobacillales.
- Antibiotic treatment resulted in a significant decrease in Coriobacteriales and Clostridiales.
- [1.1] Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls  
- [1.2] Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization  
- [1.3] Dysbiosis of skin microbiota in psoriatic patients: co-occurence of fungal and bacterial communities  
- [1.4] Dysbiosis of gut microbiota was closely associated with psoriasis  
- [1.5] The Akkermansia muciniphila is a gut microbiota signature in psoriasis  
- [1.6] Gut microbiota dysbiosis in a cohort of patients with psoriasis  
- [1.7] Microbiome-host interplay in atopic dermatitis and psoriasis  
- [1.8] Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients  
- [1.9] Gut microbial composition in patients with psoriasis  
- [1.10] Salivary microbiota and inflammation-related proteins in patients with psoriasis  
- [1.11] Community differentiation of the cutaneous microbiota in psoriasis  
- [1.12] Distribution of Malassezia species in patients with psoriasis and healthy individuals in Tehran, Iran  
- [1.13] Molecular characterization of the skin fungal microbiome in patients with psoriasis  
- [1.14] Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions  
- [1.15] Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis  
- [1.16] Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis  
- [1.17] Substantial alterations of the cutaneous bacterial biota in psoriatic lesions.  
- [1.18] Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin.  
- [1.19] Decreased bacterial diversity characterizes an altered gut microbiota in psoriatic arthritis and resembles dysbiosis of inflammatory bowel disease.  
- [1.20] Skin microbiota of first cousins affected by psoriasis and atopic dermatitis  [Review] 
- [1.21] Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response  [Research]